We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Be Conservative in Late-Phase Trials, Experiment in Early Phases: Expert
Be Conservative in Late-Phase Trials, Experiment in Early Phases: Expert
September 26, 2012
Sponsors banking on a regulatory approval should play it safe in late-stage drug trials.